- Aktuelle Seite:
-
Home
-
Politik
-
International
- Iran. Decades After Alcohol Ban, Iran Admits It Has a Problem
EMCDDA. Programming document 2019-21
Summary
This is the first Programming Document fully grounded in the EMCDDA Strategy 2025 and it sets a milestone in the strategic and operational planning framework of the EMCDDA. Among the highlights for this period will be a follow up on the outcome of the fourth external evaluation of the EMCDDA. An ongoing priority will be the implementation of the EU Early Warning System on new psychoactive substances (EU EWS). A comprehensive overview of new, changing or emerging threats will be provided by the third strategic analysis EU Drug Markets Report that will be launched jointly with Europol in 2019. (EMCDDA,Lissabon,März 2019)
http://www.emcdda.europa.eu/publications/work-programmes-and-strategies/2019-programming-document_en
Tobacco control policies and smoking among older adults: a longitudinal analysis of 10 European countries.
Serrano-Alarcón, M., Kunst, A. E., Bosdriesz, J. R., and Perelman, J. ( 2019)
Addiction, doi.org/10.1111/add.14577.
https://onlinelibrary.wiley.com/doi/10.1111/add.14577
UNODC. What we have learned over the last ten years: A summary of knowledge acquired and produced by theUN system on drug-related matters
UN system coordination Task Team on the Implementation of the UN System Common
Position on drug-related matters
Wien, März 2019
The UN Chief Executives Board unanimously endorses decriminalisation of people who use drugs.
The Chief Executives Board of the UN, representing 31 UN agencies, has adopted a common position on drug policy that endorses decriminalisation of possession and use. This comes just days before a key meeting of the Commission on Narcotic Drugs in Vienna, which will review, the UN’s 10-year Global Drug Strategy, and plan for the next one. (Transform, UK/Mexiko, 14.03.2019)
https://transformdrugs.org/un-chief-executives-endorse-decriminalisation/
Iran. Out with the old, in with the old: Iran’s revolution, drug policies, and global drug markets
Since its 1979 revolution, Iran has developed a reputation as having some of the world’s harshest drug penalties and as an opponent of efforts to reform global drug policy. Overall, however, Iran’s drug policies have been highly varied, with some policy experimentation taking place even after the revolution. And certainly long before it, Iran experimented—perhaps more than any other country—with a wide range of policies to respond to widespread drug use and poppy cultivation, alternating between permissive and very harsh policies. (Brookings, USA, 25.01.2019)
Report of the International Narcotics Control Board for 2018
(...) A major challenge is the disparate access to and availability of internationally controlled medica-tions. People in many countries experience untreated pain and surgery without anaesthesia, including in emergency situations; in other regions, the non-rational prescription of opioid-based pain medications has contributed to a public health crisis and an increasing number of overdose deathsDespite evidence of effectiveness, the use of internationally controlled methadone and buprenor-phine for the treatment of opioid dependence is limited in some countries, including countries where there are significant levels of opioid dependence. (INCB, Wien, 05.03.2019)
INCB. Suchtstoffkontrollrat warnt vor laxer Kontrolle von medizinischem Cannabis
(aerzteblatt.de, 05.03.2019)
USA. F.D.A. Commissioner Scott Gottlieb, Who Fought Teenage Vaping, Resigns
WASHINGTON — Scott Gottlieb, the commissioner of the Food and Drug Administration, known for his aggressive efforts to regulate the tobacco and e-cigarette industries, said on Tuesday that he would resign at the end of the month. (New York Times, 05.03.2019)
https://www.nytimes.com/2019/03/05/health/scott-gottlieb-resigns-fda.html
Schweiz. Pilotversuche mit Cannabis: Botschaft an das Parlament überwiesen
Bern, 28.02.2019 - Der Bundesrat hat die Botschaft zu Pilotversuchen mit Cannabis an seiner Sitzung vom 27. Februar 2019 an das Parlament überwiesen. Die Vorlage schafft die Voraussetzungen für die Durchführung von befristeten und streng reglementierten wissenschaftlichen Studien über den Cannabiskonsum zu Genusszwecken. (Schweizerische Eidgenossenschaft, Der Bundesrat, 28.02.2019)
https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen/bundesrat.msg-id-74154.html
USA. Reducing Opioid Prescriptions Saves Lives But Also Leads to More Heroin Use and Deaths
A new study finds that while reducing opioid prescriptions can save lives, it also can lead to increased heroin use and deaths, The New York Times reports. (drugfree.org, USA, 06.03.2019)
As Expected The UN Delays Voting On Cannabis
Predictably, the United Nations Commission on Narcotic Drugs (CND) will not vote on the World Health Organization’s cannabis recommendations at its upcoming meeting on March 7, in Vienna. (Forbes, USA, 26.02.2019)
USA. The Opioid Crisis Isn’t White
Contrary to media portrayals, overdose deaths are ravaging communities of color. (New York Times, Opinion, 26.02.2019)
https://www.nytimes.com/2019/02/26/opinion/opioid-crisis-drug-users.html
Russland. Russland kämpft gegen zu viel Alkohol
(sueddeutsche.de, 25.01.2019)
USA. Opioid crisis protesters target New York's Guggenheim over Sackler family link
Demonstrators call on museum to refuse donations from the owners of OxyContin. (The Guardian, UK, 10.02.2019)
USA. Study Finds Inadequate FDA Oversight of Monitoring of Fentanyl Products
FOIA-based investigation suggests important missed opportunities for FDA and manufacturers
A study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that the Food and Drug Administration (FDA) and manufacturers did not take action when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.
The study was published February 19 in the Journal of the American Medical Association. (Johns Hopkins Bloomberg School of Public Health, USA, 19.02.2019)
Europa. Nutzung von Arzneimitteln auf Cannabis-Basis fördern
In einer am Mittwoch angenommenen Entschließung fordern die Abgeordneten die Kommission und die nationalen Behörden auf, eindeutig zwischen Arzneimitteln auf Cannabis-Basis und anderen Anwendungen von Cannabis zu unterscheiden. Kommission und Mitgliedstaaten sollen die regulatorischen, finanziellen und kulturellen Hindernisse beseitigen, vor denen die Forschung hier steht. Die Forschung sollte angemessen finanziert und medizinisches Personal besser über medizinisches Cannabis informiert werden. (Europäisches Parlament, Straßburg, 13.02.2019)
Why Europe Has Dodged America's Fentanyl Crisis
Europe's most lucrative heroin markets seem ripe for a fentanyl takeover. But why the no-show? (Vice, UK, 07.02.2019)
https://www.vice.com/en_uk/article/9kpkb5/why-europe-has-dodged-americas-fentanyl-crisis
USA. 5 Things We Now Know After 5 Years of Legal Marijuana in Colorado [FEATURE]
It's been five years since the era of legal marijuana sales began in Colorado, and that's been enough time to begin to be able to see what sorts of impact the freeing of the weed has had on the Rocky Mountain State. From the economy and the fiscal health of the state government to law enforcement and public safety, legalizing marijuana has consequences. (stopthedrugwar.org, USA, Issue #1055, 16.01.2019)
https://stopthedrugwar.org/chronicle/2019/jan/16/5_things_we_now_know_after_5
Europa. Alcohol consumption, harm and policy response fact sheets for 30 European countries (2018)
The 30 country fact sheets for EU Member States, Norway and Switzerland present data on consumption, harm and policy implementation for the year 2016, aiming to give guidance to national decision-makers for further priority-setting in the field of alcohol and public health. Besides trends in alcohol consumption, each fact sheet features a section on alcohol consumption and alcohol-attributable harm, with special attention to young people, and a section on the implementation of key alcohol control policies, including the three WHO “best buys” – price increase, limits on availability and bans on advertising of alcohol. This allows for a quick overview of important subsets of alcohol policy measures that will support countries to assess their own progress towards reducing the burden of noncommunicable diseases and their key risk factors. The fact sheets also present, for the first time, an individual overview of the composite indicator scores of the 10 areas of action to reduce the harmful use of alcohol. (World Health Organization 2018)
Europa. New WHO factsheets reveal Europe struggles to implement policies to reduce alcohol consumption
The WHO European Region struggles with one of the highest levels of alcohol-related deaths in the world. To discuss effective and evidence-based ways to reverse this trend, Member States met in Stockholm, Sweden, at the first regional consultation focused on the implementation of the European action plan to reduce the harmful use of alcohol 2012–2020. (WHO, Regional Office for Europe, 31.01.2019)
USA. Philadelphia Cracks Down on Drug-User Camp, Creates More Suffering
Just after 5 am on January 31, a small army of police, city officials and outreach workers descended on the East Kensington neighborhood of Philadelphia. Its goal was to remove “Emerald City” (pictured above), the last of four drug-user camps that popped up in the wake of the 2017 closure of “El Campamento”—a sizable, largely hidden drug-user site in West Kensington that became a subject of sensationalized media reports. (Filter Magazine, USA, 01.02.2019)
https://filtermag.org/2019/02/01/philadelphia-cracks-down-on-drug-user-camp-creates-more-suffering/
USA. National Drug Control Strategy - A Report by the Office of National Drug Control Policy
JANUARY 2019
https://www.whitehouse.gov/wp-content/uploads/2019/01/NDCS-Final.pdf
USA. Cannabis Use Disorder: The Policy Climate Matters
Adolescents and young adults living in states with more liberal policies reported higher average rates of past-year cannabis use than those in states with more conservative policies, according to a new study conducted at Columbia University Mailman School of Public Health. However, the rates of cannabis use disorder—abuse or dependence on the drug—were significantly lower in states with more liberal policies compared to states with more conservative policies, for ages 12 to 17, and marginally lower for ages 26 and older. These results remained significant even when controlling for the presence of medical cannabis laws. This study is one of the first to assess the relationship between policy liberalism and health outcomes, and specifically cannabis use-related outcomes. The findings are published in the International Journal of Drug Policy. (Columbia University Mailman School of Public Health, USA, 23.01.2019)
https://www.mailman.columbia.edu/public-health-now/news/cannabis-use-disorder-policy-climate-matters
"A more accurate understanding of drug use": A critical analysis of wastewater analysis technology for drug policy.
Lancaster K, Ritter A, Valentine K, Rhodes T.
Int J Drug Policy. 2018 Nov 26;63:47-55. doi: 10.1016/j.drugpo.2018.10.011.
https://www.sciencedirect.com/science/article/pii/S0955395918302731
USA. USING MEDICATION ASSISTED TREATMENT TO TREAT OPIOID USE DISORDER: LEARNING FROM PAST EXPERIENCE TO GUIDE POLICY
MARK W. PARRINO, M.P.A., PRESIDENT
AATOD - The American Association for the Treatment of Opioid Dependence, 2019
http://www.aatod.org/wp-content/uploads/2019/01/2019-Policy-Paper-4.pdf
USA. Of All People: The DEA Demolishes One of Trump's Main Claims About the Border Wall
As the president attempts to make his case for a wall on the US-Mexico border, one of his main selling points is that the wall would reduce the flow of illicit drugs into the country. Of all people, it's not our favorite agency that has rebutted the claim.
That agency is the Drug Enforcement Administration (DEA), which in its 2018 National Drug Threat Assessment released just two months ago makes clear that at best Trump is uninformed and at worst that he is lying to the American people. (Stop the Drug War, USA, Issue 1051, 08.01.2019)
https://stopthedrugwar.org/chronicle/2019/jan/08/all_people_dea_demolishes_one
USA. Senate Confirms James Carroll as New Drug Czar
The US Senate on Wednesday confirmed by voice vote President Donald J. Trump's pick of an experienced Washington lawyer for the post informally known as the nation's drug czar. (Medscape, USA, 03.01.2019)
https://www.medscape.com/viewarticle/907204
USA/China. China Can’t Solve America’s Fentanyl Problem
Why a Crackdown Won’t Fix the Opioid Crisis. (Foreign Affairs, USA. 02.01.2019)
https://www.foreignaffairs.com/articles/china/2019-01-02/china-cant-solve-americas-fentanyl-problem
USA. F.D.A. Accuses Juul and Altria of Backing Off Plan to Stop Youth Vaping
WASHINGTON — The Food and Drug Administration is accusing Juul and Altria of reneging on promises they made to the government to keep e-cigarettes away from minors. (New York Times, 04.01.2019)
https://www.nytimes.com/2019/01/04/health/fda-juul-altria-youth-vaping.html
Seite 1 von 18